technology
FinCanna’s QVI Looks to Become California’s Premier Contract Manufacturer
California’s cannabis industry is projected to reach $7.7 billion in revenue by 2021, according to *BDS Analytics and Arcview Group, driven by the legalization of adult-use cannabis. Within this market, manufactured products, edibles, and concentrates have outpaced cannabis flower to become the *fastest growing segment of the market. Concentrates can be incorporated into many different […]
The Unique Advantages, and Challenges, of Multi-State Operators
As the cannabis industry continues to mature, an increasing number of companies are choosing to become multi-state operators, with assets and operations in a number of US legal markets. Most have achieved this through the acquisition of companies with existing assets and licenses in target states, which most often become regional subsidiaries, allowing companies to […]
Israel Builds Dominant Position in the Global Medical Cannabis Industry
Israel has always been a leader in cannabis research and development—thanks to Raphael Mechoulam’s groundbreaking research—but it’s just starting to realize the potential for cultivation. In addition to having one of the highest per capita usage rates in the world, Israel is expected to soon have upwards of 50,000 patients on a waitlist and is […]
THC BioMed Engages CFN Media to Support its Public Market Strategy
VANCOUVER, May 22, 2019 THC.CSE THCBF – OTC TFHC.F VANCOUVER, May 22, 2019 /CNW/ – THC BioMed Intl Ltd. (“THC“, or the “Company“) (CSE: THC) announces that they are engaging CFN Media to conduct a 6-month investor and market visibility program beginning towards the end of May, 2019. Compensation for the public markets program will be USD $10,000 per month. CFN […]
Sublime’s Stellar Team Sets It Apart in Cannabis Edibles
Sublime Canna, an award-winning cannabis manufacturing company located in California, has made headlines for the launch of Dosies, a cannabis-infused mint that’s both designed to be a throwback to the days of Tic Tacs and a way to consistently microdose specific cannabinoids. Unlike many edibles manufacturers, novelty isn’t the company’s only differentiating factor. The experienced […]
FSD Pharma Brings in World-Renowned Experts to Build Bioscience Division
The cannabis industry is quickly maturing from home grows and bongs to industrial-scale cultivation and innovative new product formats. At the core of this transformation, science is helping transform medical cannabis into cutting-edge pharmaceuticals and recreational cannabis into compelling alternatives to tobacco and alcohol. Companies that recognize the role of science are best positioned to […]
Cannabis Pioneer Strainwise Takes an Innovative Approach to the Industry
STWC Holdings Inc. (OTCQB: STWC), better known as Strainwise®, was founded by two cannabis industry pioneers that aim to transform their consulting practice into a national cannabis enterprise. Co-founder/CEO Erin Phillips acquired the first recreational cannabis license in the world for one of her clients, The Annie’s: A STRAINWISE® Branded Dispensary in Central City, Colorado. […]
FinCanna Combines Investment & Industry Expertise to Capitalize on California
California’s cannabis industry is projected to reach $7.7 billion by 2022, according to BDS Analytics and Arcview Group, making it the largest medical and recreational cannabis market in North America. While there are many different investment opportunities in the state, the best companies have innovative business models that avoid future commoditization issues and maximize scalability […]
Halo Labs: Building a Cannabis Concentrates Empire
Cannabis concentrates are projected to reach $8 billion by 2022, according to BDS Analytics and Arcview Market Research, making it the fastest growing of the three major segments of the legal cannabis market (flower, concentrates, and edibles). In particular, vaporizers sales soared from less than $100 million in 2014 to more than half of total […]
Isracann Raises C$10.1 Million in Bid to Supply European Market with Israeli Cannabis
The global cannabis industry is projected to be worth nearly $150 billion by 2025, according to Grand View Research, driven by the liberalization of cannabis laws around the world. Many investors have been focused on North America given Canada’s move to legalize recreational use and the growing number of states doing the same. However, Europe’s […]
Is Sustainable Cannabis Farming Possible?
Farming, in general, is pretty resource intensive. Cannabis farming can be even more so. One study from 2012 estimated that indoor cannabis cultivation accounted for 1% of the total electricity used in the United States, representing about $6 billion in annual expenditures. That study was done before the wave of legalization hit the US. In […]
Canntab Receives Cultivation Licence for Industrial Hemp
Enables Canntab to Leverage Properties in Saskatchewan and Ontario to Cultivate High Quality Hemp for the Extraction of Cannabidiol (CBD) Additionally, Canntab’s application is currently “In Progress” to obtain a Cannabis Licence (Processing- Standard, Federal Sales – Medical) from Health Canada at its Markham, Ontario facility. TORONTO, May 21, 2019 /CNW/ – Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQX:CTABF) (FRA:TBF1.F) […]
Distribution, Brands, and Revenue Growth are Key for Emerging Cannabis Companies
As the legal cannabis market matures across North America, the story is slowly turning from potential to reality. Companies are being examined more closely than ever to gauge which ones have staying power, which ones are executing on long-heralded plans, and which ones are actually creating revenue from whatever it is they are selling. There […]
Emerald’s ultra-pure SYNC 25 CBD oil fills significant need in BC’s recreational marketplace, offering a non-THC, smoke-free alternative VANCOUVER, British Columbia, May 17, 2019 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has shipped 6,000 40 ml units of its SYNC 25 CBD oil to the British Columbia Liquor Distribution Branch […]
Halo Labs Revenue Triples After Expansion into California & Nevada
Halo Labs Inc. (NEO: HALO) (OTCQX: AGEEF) revenue tripled to more than $8.7 million after launching cannabis oil and concentrate operations in California and Nevada. The company’s California operations generated $5,324,396 in revenue; it’s Nevada-based business generated $514,365 in revenue; and its existing Oregon operations reported a 32.8% increase in revenue to $2,168,975 for the […]
Supreme Cannabis’ 7ACRES Facility Approved for Additional 50,000 Square Feet of Production Capacity
Licensed space at 7ACRES increases to 230,000 sqft. Target annual production capacity is estimated to increase by 28% to approximately 33,580kg. Supreme Cannabis expects to submit additional rooms for Health Canada approval in the near term. TORONTO, May 13, 2019 /PRNewswire/ – The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSX: FIRE) (OTCQX: SPRWF) […]
Grown Rogue Talks Growth Strategy in Exclusive Interview
Multi-state operators, or MSOs, have become increasingly common across the United States given their economies of scale. With the industry’s relatively easy access to capital, many of these MSOs have bought up assets at all costs to rapidly build a footprint. Investors may want to avoid some of these companies and seek out those that […]
FSD Pharma CEO Lays Out Roadmap in Exclusive Interview with CFN Media
FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) is a licensed producer focused on building out a 3.9 million sq. ft. indoor hydroponic facility near Toronto capable of producing 400,000 kilograms of dried cannabis per year. With a newly acquired sales license and 25,000 sq. ft. already in production, the company is on the cusp of […]
Pascal Biosciences Announces Formation of Clinical Advisory Board
Preeminent Neuro-Oncology Experts to Guide PAS-403 Development Efforts VANCOUVER, British Columbia and SEATTLE, May 08, 2019 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS)(“Pascal” or the “Company”), a drug discovery and development company, today announced it has formed a clinical advisory board (“CAB”) of preeminent neuro-oncology experts to guide its PAS-403 therapeutic program. PAS-403 is Pascal’s clinical […]
Halo Labs Improves Transparency with Move to OTCQX
Many Canadian cannabis companies trade on the OTC Markets rather than a national exchange due to restrictive U.S. cannabis regulations and higher costs. While many U.S. investors have access to OTC-listed securities, there is a wide range of transparency levels that can impact investment decisions and liquidity. The OTCQX® is the highest tier of the […]
FSD Pharma Investments Pay Off Amid ‘Robust Expansion’ at Ontario Facility
FSD Pharma’s strategic investment portfolio valued at $18 million after a market-to-market unrealized gain of $10 million. Management remains tightly focused on ’robust expansion’ plan at its Cobourg, Ontario facility under the leadership of Dr. Sara May. Balance sheet includes $22 million in cash, as of December 31, 2018, with total net assets in excess […]
NexTech Signs Reseller Agreement with Foottraffik Cannabis Dispensary Software Company
New York, New York and Toronto, Ontario–(Newsfile Corp. – April 26, 2019) – NexTech AR Solutions (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29) (the “Company” or “NexTech”) today announced it has entered into a reseller agreement with Foottraffik, a dispensary marketing software and full service agency for the cannabis industry. The reseller agreement will enable Foottraffik to […]
Why Cannabis Genetics Matter & How to Invest in Innovations
Cannabis cultivators and budtenders love to talk about genetics. While everyone has an opinion on the effects of specific strains, recent research suggests that the effects of cannabis aren’t necessarily consistent with strains, and the generally accepted classifications of indiva, sativa and hybrid varieties may be flawed. Very few companies are investing in truly understanding […]
MediPharm Labs Executing on International Cannabis Extracts Strategy
Canadian companies have a bit of a head start on those from other countries where the legal cannabis framework is not as comprehensive or advanced. In many ways, countries around the globe look to Canada as a model. In fact, Australia has basically adopted Canadian medical regulations and is a few years behind Canada in […]
Halo Expands Branded Products & Launches Hemp CBD Products
The cannabis industry is projected to reach $146.4 billion by 2025, according to Grand View Research, driven by the legalization of recreational cannabis across a growing number of states and countries. While there are many different opportunities in the space, there are only a handful of companies that have proven their ability to generate significant […]
TransCanna Acquires Massive Vertically Integrated Cannabis Facility in California
California’s cannabis industry is projected to generate more than $6.5 billion in annual revenue by 2020, according to New Frontier Data and Arcview Market Research, which represents a 23.1% compound annual growth rate. Many companies are racing to build their production footprint, introduce new brands, expand distribution, and open new dispensaries, but few have reached […]
FSD Pharma Secures Sales License for Massive Production Facility
Canada’s cannabis industry has experienced tremendous growth over the past several years, following the legalization of medical and adult-use cannabis. In addition to growing domestic demand, the country’s move to federally regulate cannabis has opened the door for its licensed producers to export products around the world. These dynamics have made licensed producers a valuable […]
The Spotlight Shines on CFN Media’s Clients at The O’Cannabiz Awards
The O’Cannabiz Conference and Expo is coming to Toronto on April 25, bringing together thousands of cannabis experts and brands. Ricki Lake, Montel Williams, Jacqui Childs, Henry Rollins and other famous personalities will be featured speakers at the High Canada Magazine #1 Cannabis Event in Canada, while investors can learn about topics ranging from policy […]
CFN Media to Film Exclusive Interviews at Benzinga Cannabis Capital 2019
The Benzinga Cannabis Capital Conference returns to Toronto this week, bringing together cannabis entrepreneurs and investors from across North America. CFN Media will be at the conference filming exclusive interviews with leading startups, public companies and investment firms involved in the space to deliver cutting-edge insights. We will also be talking to familiar faces like […]
Why Women, the Fastest Growing Consumers of Cannabis, are the Demographic to Watch
Although women control around $30 trillion in annual spending, the majority of companies often ignore this powerhouse of a demographic. Millennial women in particular tend to enjoy an above-average household income, and have been estimated to represent a $170 billion dollar market. Despite being a newer industry with a keen ability to identify exciting new […]
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
Tom Zuber is Zuber Lawler & Del Duca’s Managing Partner. He has a degree with highest honors in biomedical engineering and has advised some of the most iconic companies in the world on their patent and trademark portfolios. He is at the cutting edge of cannabis patent and trademark law. He holds degrees from Harvard University and Columbia Law […]
Ehave, Inc. (EHVVF) is a leader in digital therapeutics delivering evidence-based therapeutic interventions to patients.
Lexaria Corp is an aspiring producer of medical marijuana under Canada’s Marihuana for Medical Purposes Regulations (“MMPR”). On March 5, 2014, the company signed a joint venture with Enertopia Corp. (OTC: ENRT) (CSE: TOP) with the goal of bringing a 60,000 square foot cultivation facility online.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
